# Treatment Outcomes Under a Standardized Treatment Protocol in Patients Suffered Substance Abuse Related Voiding Dysfunction

> **NCT03913819** · — · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 1000 (estimated)

## Conditions studied

- Voiding Dysfunction
- Substance Abuse

## Interventions

- **DRUG:** First line treatment: oral NSAID and anticholinergic agents
- **DRUG:** Second line treatment: additional treatment for pain control
- **DRUG:** Third line treatment: A course of intravesical hyaluronate will be given.
- **PROCEDURE:** Fourth line treatment: surgical intervention

## Key facts

- **NCT ID:** NCT03913819
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2011-12-10
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03913819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03913819, "Treatment Outcomes Under a Standardized Treatment Protocol in Patients Suffered Substance Abuse Related Voiding Dysfunction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03913819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*